X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1249) 1249
pregnancy (1082) 1082
female (1067) 1067
humans (997) 997
preeclampsia (530) 530
obstetrics & gynecology (456) 456
animals (417) 417
adult (373) 373
hypertension (270) 270
placenta (256) 256
infant, newborn (196) 196
placenta - blood supply (191) 191
reproductive biology (176) 176
obstetrics and gynecology (167) 167
risk factors (165) 165
analysis (156) 156
male (153) 153
pre-eclampsia (150) 150
oxidative stress (149) 149
placenta - metabolism (148) 148
placental growth factor (144) 144
pregnant women (144) 144
placenta - pathology (143) 143
health aspects (141) 141
placental ischemia (140) 140
pre-eclampsia - physiopathology (140) 140
rats (139) 139
expression (135) 135
intrauterine growth restriction (135) 135
developmental biology (134) 134
gestational age (134) 134
angiogenesis (133) 133
hypoxia (127) 127
pediatrics (127) 127
abridged index medicus (125) 125
physiology (122) 122
women (122) 122
fetus (119) 119
article (114) 114
internal medicine (114) 114
peripheral vascular disease (112) 112
pre-eclampsia - blood (109) 109
pre-eclampsia - metabolism (109) 109
disease models, animal (106) 106
young adult (106) 106
growth (105) 105
vascular endothelial growth factor (105) 105
case-control studies (104) 104
research (104) 104
physiological aspects (102) 102
pathology (100) 100
blood pressure (99) 99
cell biology (94) 94
infants (92) 92
biomarkers - blood (90) 90
placental growth-factor (86) 86
inflammation (85) 85
placenta growth factor (85) 85
placental circulation (85) 85
apoptosis (84) 84
fetuses (84) 84
risk (84) 84
ischemia (82) 82
mice (79) 79
pregnancy outcome (77) 77
rats, sprague-dawley (77) 77
retrospective studies (77) 77
prospective studies (76) 76
medicine, research & experimental (75) 75
fetal growth retardation - physiopathology (74) 74
endothelial growth-factor (73) 73
medicine & public health (73) 73
placental insufficiency (73) 73
pre-eclampsia - pathology (73) 73
biochemistry & molecular biology (71) 71
placental abruption (71) 71
rodents (69) 69
soluble endoglin (69) 69
embryonic structures (67) 67
endothelium (66) 66
pathogenesis (66) 66
pre-eclampsia - etiology (65) 65
pregnancy complications (65) 65
medicine (62) 62
placenta - physiopathology (61) 61
ultrasonography, prenatal (61) 61
uterus - blood supply (61) 61
angiogenic factors (60) 60
care and treatment (60) 60
fetal growth retardation - etiology (60) 60
fetal-growth (60) 60
immunology (60) 60
necrosis-factor-alpha (60) 60
birth weight (59) 59
gene expression (59) 59
tyrosine kinase-1 (59) 59
uterine artery doppler (59) 59
biomarkers (58) 58
blood-pressure (58) 58
cytokines (57) 57
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1456) 1456
French (9) 9
German (5) 5
Spanish (5) 5
Russian (4) 4
Japanese (2) 2
Dutch (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 05/2013, Volume 305, Issue 4, pp. R397 - R403
Preeclampsia is a complication of pregnancy that is marked by hypertension, proteinuria, and maternal endothelial dysfunction. A central factor in the etiology... 
Pregnancy | Soluble fms-like tyrosine kinase | Phosphodiesterase-5 | Vascular endothelial growth factor | Preeclampsia | CHRONIC REDUCTIONS | PHYSIOLOGY | pregnancy | NITRIC-OXIDE SYNTHESIS | FETAL-GROWTH | phosphodiesterase-5 | soluble fms-like tyrosine kinase | NECROSIS-FACTOR-ALPHA | preeclampsia | TYROSINE KINASE-1 | BLUNTED NATRIURETIC RESPONSE | vascular endothelial growth factor | PREGNANT RATS | UTERINE PERFUSION-PRESSURE | Piperazines - administration & dosage | Antihypertensive Agents - pharmacology | Actins - metabolism | Antihypertensive Agents - administration & dosage | Vascular Endothelial Growth Factor A - metabolism | Purines - administration & dosage | Sulfones - pharmacology | Pre-Eclampsia - physiopathology | Sildenafil Citrate | Ischemia - complications | Arterial Pressure - drug effects | Female | Pre-Eclampsia - metabolism | Phosphodiesterase 5 Inhibitors - pharmacology | Placental Circulation - drug effects | Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism | Disease Models, Animal | Vasodilator Agents - pharmacology | Administration, Oral | Purines - pharmacology | Kidney Medulla - drug effects | Phosphodiesterase 5 Inhibitors - administration & dosage | Ischemia - metabolism | Rats | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Ischemia - physiopathology | Piperazines - pharmacology | Pre-Eclampsia - etiology | Rats, Sprague-Dawley | Placenta - drug effects | Placenta - metabolism | Placenta - blood supply | Animals | Pre-Eclampsia - drug therapy | Cyclic GMP - metabolism | Kidney Medulla - metabolism | Vasodilator Agents - administration & dosage | Sulfones - administration & dosage | Hypertension | Reproductive system | Ischemia | Index Medicus | Fluid and Electrolyte Homeostasis
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0132063 - e0132063
Preeclampsia is characterized by reduced placental perfusion with placental ischemia and hypertension during pregnancy. Preeclamptic women also exhibit a... 
SPRAGUE-DAWLEY RATS | PREGNANCY-INDUCED HYPERTENSION | OXIDATIVE STRESS | COMPLEMENT ACTIVATION | NITRIC-OXIDE INHIBITION | MULTIDISCIPLINARY SCIENCES | ANGIOGENIC IMBALANCE | REDUCED UTERINE PERFUSION | NECROSIS-FACTOR-ALPHA | BLOOD-PRESSURE | ENDOTHELIAL GROWTH-FACTOR | Immune Sera | Oxidative Stress | Hypertension, Pregnancy-Induced - blood | Pre-Eclampsia - physiopathology | Pre-Eclampsia - prevention & control | Ischemia - immunology | Leukocyte Reduction Procedures | Ischemia - complications | Placental Circulation | Female | Complement C3a - analysis | Leukocyte Count | Disease Models, Animal | Neutrophils - immunology | Neutrophils - physiology | Vascular Endothelial Growth Factor A - blood | Rats | Hypertension, Pregnancy-Induced - physiopathology | Ischemia - physiopathology | Hypertension, Pregnancy-Induced - immunology | Immunity, Innate | Pre-Eclampsia - etiology | Rats, Sprague-Dawley | Pregnancy | Placenta - blood supply | Animals | Hypertension, Pregnancy-Induced - prevention & control | Hypertension, Pregnancy-Induced - etiology | Pre-Eclampsia - immunology | Hypertension | Ischemia | Comparative analysis | Oxidative stress | Complement component C3a | Pathogenesis | Lung | Premature birth | Infections | Medical schools | Arteries | Cell activation | Uterus | Rodents | Surgery | Aorta | Leukocytes (polymorphonuclear) | Tumor necrosis factor-TNF | Blood pressure | Vascular endothelial growth factor | Immune system | Fetuses | Neutrophils | Leukocytes (neutrophilic) | Inflammation | Pre-eclampsia | Catheters | White blood cells | Complement activation | Depletion | Placenta | Perfusion | Preeclampsia | Index Medicus
Journal Article
American journal of physiology. Regulatory integrative comparative physiology, ISSN 0363-6119, 02/2017, Volume 312, Issue 5, pp. R664 - R670
Journal Article
Journal Article
Molecular Immunology, ISSN 0161-5890, 10/2019, Volume 114, pp. 10 - 18
Preeclampsia is characterized by new onset hypertension and fetal growth restriction and is associated with aberrant activation of the innate immune complement... 
Pregnancy | Complement | Placental ischemia | Endothelin | Index Medicus
Journal Article
Journal Article
BBA - Molecular Cell Research, ISSN 0167-4889, 02/2015, Volume 1853, Issue 2, pp. 422 - 430
Mesenchymal stem cells are potent candidates in stroke therapy due to their ability to secrete protective anti-inflammatory cytokines and growth factors. We... 
Neuroprotection | Reperfusion | Conditioned medium | Ischemia | Semaxanib | Oxygen and glucose deprivation | NGF-differentiated PC12 cells | VEGF | Human placental mesenchymal-like adherent stromal cells (PLX) | IL-6 | stromal cells (PLX) | STEM-CELLS | SERUM DEPRIVATION | IN-VITRO ISCHEMIA | POSSIBLE INVOLVEMENT | INDUCED APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INJURY | EXPERIMENTAL STROKE | CELL BIOLOGY | UMBILICAL-CORD BLOOD | INDUCED NEUROTOXICITY | CEREBRAL-ISCHEMIA | Human placental mesenchymal-like adherent | L-Lactate Dehydrogenase - metabolism | Cell Count | Humans | Culture Media, Conditioned - pharmacology | Spin Labels | PC12 Cells | Neuroprotective Agents - metabolism | Vascular Endothelial Growth Factor A - secretion | Nerve Growth Factors - pharmacology | Mesenchymal Stromal Cells - cytology | Cyclic N-Oxides - pharmacology | Placenta - cytology | Lipid Peroxidation - drug effects | Female | Indoles - pharmacology | Cell Death - drug effects | Ischemia - pathology | Antibodies, Monoclonal - pharmacology | Rats | Cell Adhesion - drug effects | Interleukin-6 - secretion | Pregnancy | Pyrroles - pharmacology | Animals | Cell Differentiation - drug effects | Cell Proliferation - drug effects | Mice | Stroke (Disease) | Glucose metabolism | Endothelial growth factors | Analysis | Stem cells | Nerve growth factor | Glucose | Dextrose
Journal Article